Influenza Drug Therapy

The influenza virus is a common viral infection that can rapidly evolve and render previous vaccines ineffective. There are two types of FDA approved drug treatments for the influenza virus, neuraminidase inhibitors and M2-inhibitors. Discover the latest research on influenza drug therapy here.

January 14, 2022
Review
Open Access

Advances and gaps in SARS-CoV-2 infection models.

PLoS Pathogens
César Muñoz-FontelaDan H Barouch
January 14, 2022

Has the COVID-19 pandemic wiped out the seasonality of outpatient antibiotic use and influenza activity? A time-series analysis from 2014 to 2021.

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Ana Belén Guisado-GilJosé Miguel Cisneros
January 13, 2022

[Mucosal immunity and vaccines against viral infections].

Voprosy virusologii
S S ZainutdinovG V Kochneva
January 12, 2022

Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave.

Proceedings of the National Academy of Sciences of the United States of America
Nathaniel HupertDouglas F Nixon
January 12, 2022

The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses.

Cellular and Molecular Life Sciences : CMLS
André SchreiberStephan Ludwig
January 11, 2022

Expression and characterization of a recombinant broadly-reactive monoclonal antibody against group 1 and 2 influenza viruses.

Protein Expression and Purification
Zenglei HuXiufan Liu
January 9, 2022
Preprint
Open Access

A single amino acid substitution in PB1 of pandemic H1N1 with A/Ann Arbor/6/60 master donor virus mutations as a novel live-attenuated influenza virus vaccine

BioRxiv : the Preprint Server for Biology
A. NogalesLuis Martinez-Sobrido
January 4, 2022
Preprint
Open Access

The 2009 pandemic H1N1 hemagglutinin stalk remained antigenically stable after circulating in humans for a decade

BioRxiv : the Preprint Server for Biology
S. R. ChristensenScott E. Hensley
January 4, 2022

SARS-CoV-2 in hospital air as revealed by comprehensive respiratory viral panel sequencing.

Infection Prevention in Practice
Nazima HabibiAnisha Shajan
January 4, 2022
Open Access

Neuraminidase1 Inhibitor Protects Against Doxorubicin-Induced Cardiotoxicity via Suppressing Drp1-Dependent Mitophagy.

Frontiers in Cell and Developmental Biology
Yating QinXiaomei Guo
January 4, 2022
Open Access

Reassortment Network of Influenza A Virus.

Frontiers in Microbiology
Xingfei GongHongguang Ren
December 31, 2021
Open Access

Designing a multi-epitope vaccine to provoke the robust immune response against influenza A H7N9.

Scientific Reports
Hossein TarrahimofradSaeed Aminzadeh
December 29, 2021

Comprehensive serologic profile and specificity of maternal and neonatal cord blood SARS-CoV-2 antibodies.

AJOG Global Reports
Rupsa C BoeligE. C. Bergmann-Leitner
December 29, 2021
Review

[Research and development technology platform and research progress of universal influenza vaccine].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
T DengX M Yang
December 28, 2021
Open Access

Human Properdin Released By Infiltrating Neutrophils Can Modulate Influenza A Virus Infection.

Frontiers in Immunology
Praveen M VargheseUday Kishore
December 28, 2021

Novel reassortment 2.3.4.4b H5N8 highly pathogenic avian influenza viruses circulating in Xinjiang, China.

Preventive Veterinary Medicine
Nana ChangZhenghai Ma
December 25, 2021
Open Access

In Silico Prediction and Bioactivity Evaluation of Chemical Ingredients Against Influenza A Virus From Isatis tinctoria L.

Frontiers in Pharmacology
Chuipu CaiGuan-Hua Du

Sign up to follow this feed and discover related papers.

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

© 2022 Meta ULC. All rights reserved
/feed-previews/influenza-drug-therapy/c666b72e-0a4d-4638-a97a-37979d796eef